Table 2. Non-parametric analysis of disease activity and lipid blood levels in RA patients (Spearman’s coefficient of correlation).
| Lipid blood level | DAS 28-hsCRP | DAS 28-ESR | Disease activity assessed by physician | Disease activity assessed by patient | TJC68 | SJC66 | |
|---|---|---|---|---|---|---|---|
| HDL, mmol/l | R=-0.55, p=0.006 | R=-0.67, p=0.0001 | R=-0.11, p=0.59 | R=-0.23, p=0.27 | R=-0.422, p=0.036 | R=-0.54, p=0.005 | |
| LDL, mmol/l | R=0.24, p=0.3 | R=0.39, p=0.06 | R=0.39, p=0.049 | 0.46, p=0.02 | R=0.4, p=0.047 | R=0.26, p=0.2 | |
| AI | R=0.627, p=0.001 | R=0.79, p=0.0001 | R=0.38, p=0.06 | R=0.49, p=0.01 | R=0.59, p=0.002 | R=0.57, p=0.003 | |
| Total Cholesterol, mmol/l | R=0.045, p=0.83 | R=0.1, p=0.6 |
R=0.42, p=0.028 | R=0.35, p=0.08 | R=0.25, p=0.2 | R=0.12, p=0.55 | |
LDL: low-density lipoprotein; HDL: high-density lipoprotein; AI –atherogenic index. *- p<0.05, **- p<0.005, ***- p<0.0005